A clinical trial to study effect of two drugs,sublingual misoprostol and intravenous Trenaxamic acid in primary lower segment cesarean section patients to estimate the amount of blood loss
Phase 4
- Conditions
- Health Condition 1: O94-O9A- Other obstetric conditions, not elsewhere classified
- Registration Number
- CTRI/2021/03/032275
- Lead Sponsor
- Aarupadi Veedu Medical College and Hoppital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Full term women undergoing primary Cesarean Section at Aarupadi Veedu Medical College and Hospital who are willing to participate
Exclusion Criteria
1)Previous Cesarean Section
2)Induced/augmented labour
3)obesity
4)chorioamnionitis
5)antepartum hemorrhage
6)pre term pregnancy
7)overdistension-multipregnancy,polyhydromnios
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method amount of blood loss pre operatively (hematocrit) <br/ ><br>amount of blood loss post operatively(hematocrit)Timepoint: within 1 week of cesarean section
- Secondary Outcome Measures
Name Time Method safety, side effects, cost effectivenessTimepoint: within 1 week of cesarean section